Salta

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Familial hypercholesterolaemia2 trials
• Heart failure2 trials
• Coronary artery disease1 trial
• Stroke1 trial

Phase

• Phase 33 trials
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Completed2 trials

Lead sponsor

• Novartis Pharmaceuticals4 trials

Running trials

• Active, not recruiting

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· Phase 3· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC

  NCT04023227· Phase 4· Novartis Pharmaceuticals· Source

• Completed

  Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF

  NCT03785405· Phase 3· Novartis Pharmaceuticals· Source